Sabba Stephen L

CIK 00014423722 companiesSYOSSET, NY

SEC Profile

Transactions

Companies

Filings

CIK

0001442372

Recent Transactions

50 trades

Award
LIGAND PHARMACEUTICALS INC$LGND
Non-Qualified Stock Option (right to buy)
2025-06-06+5,783→ 5,783 total
Award
LIGAND PHARMACEUTICALS INC$LGND
Common Stock
2025-06-06+1,209→ 33,793 total
Exercise/Conversion
LIGAND PHARMACEUTICALS INC$LGND
Non-Qualified Stock Option (right to buy)
2025-04-01−2,406→ 0 total
Exercise/Conversion
LIGAND PHARMACEUTICALS INC$LGND
Common Stock
2025-04-01$52.30/sh+2,406→ 32,584 total
Award
LIGAND PHARMACEUTICALS INC$LGND
Common Stock
2024-06-14+1,252→ 30,178 total
Award
LIGAND PHARMACEUTICALS INC$LGND
Non-Qualified Stock Option (right to buy)
2024-06-14+5,444→ 5,444 total
Sale
LIGAND PHARMACEUTICALS INC$LGND
Common Stock
2024-03-05$74.30/sh−1,893→ 28,926 total
Exercise/Conversion
LIGAND PHARMACEUTICALS INC$LGND
Common Stock
2024-03-05+2,893→ 30,819 total
Exercise/Conversion
LIGAND PHARMACEUTICALS INC$LGND
Non-Qualified Stock Option (right to buy)
2024-03-05−2,893→ 419 total
Award
LIGAND PHARMACEUTICALS INC$LGND
Common Stock
2023-06-09+1,142→ 26,926 total
Award
LIGAND PHARMACEUTICALS INC$LGND
Non-Qualified Stock Option (right to buy)
2023-06-09−5,461→ 5,461 total
Sale
LIGAND PHARMACEUTICALS INC$LGND
Common Stock
2023-05-10$77.13/sh−6,408→ 25,784 total
Exercise/Conversion
LIGAND PHARMACEUTICALS INC$LGND
Non-Qualified Stock Option (right to buy)
2023-05-10−6,408→ 927 total
Exercise/Conversion
LIGAND PHARMACEUTICALS INC$LGND
Common Stock
2023-05-10+6,408→ 32,192 total
Award
LIGAND PHARMACEUTICALS INC$LGND
Non-Qualified Stock Option (right to buy)
2022-12-22+6,623→ 6,623 total
Award
LIGAND PHARMACEUTICALS INC$LGND
Non-Qualified Stock Option (right to buy)
2022-06-10−4,340→ 4,340 total
Award
LIGAND PHARMACEUTICALS INC$LGND
Common Stock
2022-06-10+1,004→ 26,065 total
Award
LIGAND PHARMACEUTICALS INC$LGND
Common Stock
2021-06-04+630→ 25,061 total
Award
LIGAND PHARMACEUTICALS INC$LGND
Non-Qualified Stock Option (right to buy)
2021-06-04−3,269→ 3,269 total
Exercise/Conversion
LIGAND PHARMACEUTICALS INC$LGND
Common Stock
2021-02-09$12.53/sh+7,335→ 39,101 total
Exercise/Conversion
LIGAND PHARMACEUTICALS INC$LGND
Common Stock
2021-02-09$10.12/sh+7,335→ 31,766 total
Sale
LIGAND PHARMACEUTICALS INC$LGND
Common Stock
2021-02-09$208.00/sh−556→ 38,545 total
Exercise/Conversion
LIGAND PHARMACEUTICALS INC$LGND
Non-Qualified Stock Option (right to buy)
2021-02-09−7,335→ 0 total
Exercise/Conversion
LIGAND PHARMACEUTICALS INC$LGND
Non-Qualified Stock Option (right to buy)
2021-02-09−7,335→ 0 total
Sale
LIGAND PHARMACEUTICALS INC$LGND
Common Stock
2021-02-09$208.55/sh−14,114→ 24,431 total
Award
LIGAND PHARMACEUTICALS INC$LGND
Common Stock
2020-06-10+831→ 24,431 total
Award
LIGAND PHARMACEUTICALS INC$LGND
Non-Qualified Stock Option (right to buy)
2020-06-10+2,468→ 2,468 total
Sale
LIGAND PHARMACEUTICALS INC$LGND
Common Stock
2019-07-31$94.45/sh−4,091→ 23,600 total
Award
LIGAND PHARMACEUTICALS INC$LGND
Non-Qualified Stock Option (right to buy)
2019-06-06+4,071→ 4,071 total
Award
LIGAND PHARMACEUTICALS INC$LGND
Common Stock
2019-06-06+835→ 27,691 total
Exercise/Conversion
LIGAND PHARMACEUTICALS INC$LGND
Common Stock
2018-09-04$8.58/sh+2,500→ 29,356 total
Exercise/Conversion
LIGAND PHARMACEUTICALS INC$LGND
Common Stock
2018-09-04$17.88/sh+2,500→ 31,856 total
Exercise/Conversion
LIGAND PHARMACEUTICALS INC$LGND
Non-Qualified Stock Option (right to buy)
2018-09-04−2,500→ 0 total
Sale
LIGAND PHARMACEUTICALS INC$LGND
Common Stock
2018-09-04$255.05/sh−5,000→ 26,856 total
Exercise/Conversion
LIGAND PHARMACEUTICALS INC$LGND
Non-Qualified Stock Option (right to buy)
2018-09-04−2,500→ 0 total
Award
NOVELION THERAPEUTICS INC.
Stock Option (Right to Buy)
2018-08-09+10,000→ 10,000 total
Award
LIGAND PHARMACEUTICALS INC$LGND
Common Stock
2018-06-19+493→ 26,856 total
Award
LIGAND PHARMACEUTICALS INC$LGND
Common Stock
2018-06-19+493→ 26,856 total
Award
LIGAND PHARMACEUTICALS INC$LGND
Non-Qualified Stock Option (right to buy)
2018-06-19+2,474→ 2,474 total
Award
LIGAND PHARMACEUTICALS INC$LGND
Non-Qualified Stock Option (right to buy)
2018-06-19+2,474→ 2,474 total
Sale
LIGAND PHARMACEUTICALS INC$LGND
Common Stock
2018-03-12$180.73/sh−622→ 26,363 total
Sale
LIGAND PHARMACEUTICALS INC$LGND
Common Stock
2017-12-20$137.25/sh−925→ 26,985 total
Award
LIGAND PHARMACEUTICALS INC$LGND
Common Stock
2017-05-25+666→ 27,910 total
Award
LIGAND PHARMACEUTICALS INC$LGND
Non-Qualified Stock Option (right to buy)
2017-05-25+2,456→ 2,456 total
Award
NOVELION THERAPEUTICS INC.
Stock Option (Right to Buy)
2016-12-22+9,600→ 9,600 total
Award
NOVELION THERAPEUTICS INC.
Stock Option (right to buy)
2016-06-17+50,000→ 50,000 total
Award
NOVELION THERAPEUTICS INC.
Phantom Stock
2016-06-17+6,400→ 28,400 total
Award
LIGAND PHARMACEUTICALS INC$LGND
Common Stock
2016-05-23+622→ 27,244 total
Award
LIGAND PHARMACEUTICALS INC$LGND
Non-Qualified Stock Option (right to buy)
2016-05-23+2,329→ 2,329 total
Exercise/Conversion
NOVELION THERAPEUTICS INC.
Stock Option (right to buy)
2015-06-29−12,500→ 0 total

Companies

Recent Filings

Address

DORSET MANAGEMENT CORP 485 UNDERHILL BLVD SUITE 205

SYOSSET, NY, 11791

View on SEC.gov